| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |